Promising Results: New Drug Shows Potential to Reduce Cholesterol Blockages - World Today News
World Today News,
In its first human trial, the experimental drug movalaplin reduced cholesterol transporters that block blood vessels at an…
In its first human trial, the experimental drug movalaplin reduced cholesterol transporters that block blood vessels at an…
In its first human trial, the experimental muvalaplin reduced vessel-clogging cholesterol-carriers at impressive rates.
England: Elevated levels of Lipoprotein(a), a subtype of "bad cholesterol," in bloodstreams are a risk factor for recurrent…
(HealthDay News) — Elevated lipoprotein(a) (Lp[a]) is a predictor of recurrent coronary heart disease (CHD) in older adults…